About Genisphere
Genisphere is a company based in Montgomery (United States) founded in 1997. Genisphere has raised $14.51 million across 4 funding rounds from investors including Lankenau Institute for Medical Research and Corporate Fuel. The company has 4 employees. Genisphere operates in a competitive market with competitors including Sirnaomics, Acorda, Liquidia, Genedit and NanoSyrinx, among others.
- Headquarter Montgomery, United States
- Employees 4
- SectorsTechnologyHealthcare
- Website genisphere.com
- Social LinkedIn X
- Legal Name Genisphere, Llc
- Total Equity Funding$14.51M (USD)
in 4 rounds
- Latest Funding Round$1.51M (USD), Series B
May 2018
- Investors
- Employee Count4
Funding Insights of Genisphere
Genisphere has successfully raised a total of $14.51M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $1.51 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.51M
- Total Rounds 4
- Last Round Series B — $1.51M
- First Round $2M
(Sep 2014)
- Investors Count 2
All 4 funding rounds of Genisphere with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2018 | $1.51M | Series B | – | – | – |
| Nov 2017 | $7M | Series B | – | – | – |
| Oct 2015 | $4M | Series A | – | – | |
| Sep 2014 | $2M | Series A | – | – |
2 investors in total: 2 institutional.
Investors in Genisphere
Genisphere has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Lankenau Institute for Medical Research and Corporate Fuel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Medical research on cancer and cardiovascular diseases is conducted. | – | limr.org | - | |
Corporate Fuel is engaged in providing investment banking and advisory services. | – | corporatefuel.com | New York, USA |
Investor details for Genisphere
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Genisphere
3 dated milestones of Genisphere across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Genisphere is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Series B, of $1.5M.
Competitors of Genisphere
Genisphere operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sirnaomics, Acorda, Liquidia, Genedit and NanoSyrinx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sirnaomics.com | 2007 | Gaithersburg, United States | $267M | 88 | RNA-based therapeutics for cancer and fibrosis are developed. | |
| acorda.com | 1995 | Ardsley, United States | $66.5M | 109 | Engaged in the development and commercialization of therapies that improve neurological function. | |
| liquidia.com | 2004 | United States | $75.3M | 63 | Engineered particles & films for life and material sciences applications | |
| genedit.com | 2016 | Berkeley, United States | $93.5M | 34 | Genetic medicines are delivered using polymer nanoparticle platforms. | |
| nanosyrinx.com | 2018 | Coventry, United Kingdom | $21.63M | 17 | Drug delivery systems to cell interiors are developed via nanosyringes. | |
| ensysce.com | 2008 | Houston, United States | $2.5M | – | Drug delivery solutions via single-walled carbon nanotubes are offered. | |
| arcturusrx.com | 2013 | San Diego, United States | $1.3M | 337 | RNAi technologies are developed for treating rare orphan diseases. | |
| clene.com | 2012 | Salt Lake, United States | $59.1M | 99 | Nanotechnology-based therapeutics for cancer and auto-immune disorders are developed. | |
| zylotherapeutics.com | 2017 | Greenville, United States | $9.43M | – | Hydrogel-derived nanoparticles for topical drug delivery are developed. |
Detailed competitors of Genisphere
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Genisphere
Websites that share an audience with Genisphere (genisphere.com).
Websites whose visitors overlap most with Genisphere. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
avidity.com | avidity.com | 100% | – | #5,465,447 | – |
immunometrics.co.uk | immunometrics.co.uk | 98% | – | – | – |
bindingsite.co.uk | bindingsite.co.uk | 98% | – | – | – |
| upstate.com | 98% | – | – | View details | |
| polyplus-transfection.com | 98% | – | – | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 21 similar websites and full traffic analytics for Genisphere
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 21 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Genisphere
Complete news archive for Genisphere
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Genisphere
10 companies that operate in the same segment as Genisphere (Nanotechnology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Developer of technologies for analysis of genetic variation and function | 1993 | San Diego, California, United States | USD 28 M | USD 1.44 M | 29 | |
RNA interference-based therapeutics are developed for multiple disorders. | 2002 | Cambridge, Massachusetts, United States | USD 17 M | USD 3.71 B | 2,230 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
Aerogel-based thermal insulation solutions are provided for energy conservation. | 2001 | United States | USD 198.35 M | USD 271.1 M | 554 | |
Nanotech-based electrode materials for supercapacitors are provided. | 2009 | Boston, Massachusetts, United States | USD 163.32 M | – | 66 | |
Instrument systems and software for single-molecule real-time sequencing are developed. | 2004 | Menlo Park, California, United States | USD 395 M | USD 160 M | 575 | |
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Conductive nanocoatings are delivered via atomic layer deposition technology. | 2013 | Boulder, Colorado, United States | USD 202.75 M | – | – | |
RNA therapeutics for hematology and cardiovascular diseases are developed. | 1999 | London, England, United Kingdom | – | USD 559 K | 116 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genisphere
Genisphere was founded in 1997 and raised its 1st funding round 17 years after it was founded.
Genisphere is headquartered in Montgomery, United States. It is registered at Montgomery, Alabama, United States.
Genisphere is a funded company, having raised a total of $14.51M across 4 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on Sep 2014.
Genisphere has 4 employees.
Genisphere develops drug delivery platform for the targeted delivery of small drugs, biologics, and nucleic acids. The company offers 3DNA, a DNA-based nanotechnology platform that has application in clinical diagnostic tests; customized 3DNA reagents for assays; and legacy 3DNA products for increased sensitivity in microarray applications, as well as other immunoassay and nucleic acid detection systems. It also provides 3DNA cargo that consists of small off-patent drug molecules, siRNAs, microRNAs, peptides, or proteins for targeted drug delivery. the company has 7 million capital raise to advance its 3DNA nanotechnology platform.
Genisphere's top competitors include Sirnaomics, Arcturus Therapeutics and Acorda.
Genisphere has 2 investors. Key investors include Lankenau Institute for Medical Research, and Corporate Fuel.
Genisphere operates through Genisphere, Llc.